Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
BACKGROUND: An acquired V617F mutation in JAK2 occurs in most patients with polycythaemia vera, but is seen in only half those with essential thrombocythaemia and idiopathic myelofibrosis. We aimed to assess whether patients with the mutation are biologically distinct from those without, and why th...
Κύριοι συγγραφείς: | Campbell, P, Scott, L, Buck, G, Wheatley, K, East, C, Marsden, J, Duffy, A, Boyd, E, Bench, A, Scott, M, Vassiliou, G, Milligan, D, Smith, SR, Erber, W, Bareford, D, Wilkins, B, Reilly, J, Harrison, C, Green, A |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2005
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
JAK2 V617F mutation identifies a biologically distinct subtype of essential thrombocythemia which resembles polycythemia vera.
ανά: Green, A, κ.ά.
Έκδοση: (2005) -
Skin cancer in essential thrombocythaemia and polycythaemia vera patients treated with hydroxycarbamide
ανά: Abhinav Mathur, κ.ά.
Έκδοση: (2022-11-01) -
Cerebral venous sinus thrombosis in JAK2 V617F positive polycythaemia vera presenting as a haemorrhagic stroke
ανά: N. T. Weerasinghe, κ.ά.
Έκδοση: (2021-12-01) -
Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
ανά: Jumoke Okikiolu, κ.ά.
Έκδοση: (2023-01-01) -
Polycythaemia vera and central sleep apnoea.
ανά: Stradling, JR, κ.ά.
Έκδοση: (1980)